Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + midazolam versus nalbuphine for analgo-sedation in post-thoracotomy ICU patients
TCTR20251226006Phase 3Completed
- Sponsor
- nill
- Start
- May 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine, midazolam, nalbuphine in postoperative pain, respiratory failure, sponsored by nill. Started May 2023; status: completed.
02
Drugs
ketaminemidazolamnalbuphine
03
Conditions
postoperative painrespiratory failure
Beyond the preview
Go deeper on TCTR20251226006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251226006.